VISCHER has advised Nuclidium AG. Walder Wyss has advised Angelini Ventures, Kurma Partners, and Wellington Partners as co-lead investors; Dentons has acted for Neva. Nuclidium AG,...
Nuclidium AG Secures CHF 79 Million in Series B Financing Round
Memo Therapeutics AG’s CHF20 Million Additional Series C Financing Round
VISCHER advised Ysios Capital and Kurma Partners. Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised...
Amolyt Pharma’s EUR 138 Million Fund Raising
Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings...
NaoX Technologies’ €4,3 Million Series Seed Financing Round
Goodwin Procter advised Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc e-Santé Invest on the deal. Kurma Partners, Bpifrance Investissement, BNP Paribas Développement and Majycc...
Amolyt Pharma’s $80 Million Series B Financing Round
Goodwin Procter advised Sectoral Asset Management and Andera Partners on the deal. McDermott Will & Emery advised a syndicate of Amolyt Pharma’s historical investors, including LSP,...
Coave Therapeutics’ €21 Million Funding Round
IN BRIEF: Bird & Bird, McDermott Will & Emery, Weil, Gotshal & Manges, advised on the matter. Bird & Bird advised Coave Therapeutics (Horama SAS) with...
Mila’s €4 Million Financing
Dechert advised the investor on the deal. Kurma Partners, BNP Paribas Développement and Bpifrance through its fund Patient Autonomy, completed their investment of a total amount of...